Anteris Technologies

Anteris Technologies company information, Employees & Contact Information

Anteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We sought to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.

Company Details

Employees
140
Founded
-
Address
860 Blue Gentian Road, Suite 340,australia
Phone
+61 1300 550 310
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Eagan, MN
Looking for a particular Anteris Technologies employee's phone or email?

Anteris Technologies Questions

News

Anteris Announces Results for the Second Quarter of 2025 - Yahoo Finance

Anteris Announces Results for the Second Quarter of 2025 Yahoo Finance

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors GlobeNewswire

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering - Business Wire

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering Business Wire

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025 - Yahoo Finance

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025 Yahoo Finance

Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - Yahoo Finance

Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) Yahoo Finance

Anteris Technologies Commences American Depository Receipt Program - Business Wire

Anteris Technologies Commences American Depository Receipt Program Business Wire

Anteris Reports 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Anteris Reports 2024 Financial Results and Provides Corporate Update Yahoo Finance

Top Anteris Technologies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant